MiMedx director granted 50,913 restricted shares

Olson Tiffany reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Olson Tiffany reported acquisition or exercise transactions in this Form 4 filing.

MIMEDX GROUP, INC. director Tiffany Olson received an award of 50,913 shares of common stock at $3.64 per share as a restricted stock grant for non-employee directors. This equity award vests upon the earlier of 12 months or the next meeting of shareholders, and is exempt under Rule 16b-3. Following the grant, she directly holds 108,510 shares of common stock. This is a compensation-related equity grant rather than an open-market purchase.

Insider Trade Summary

Grant/Award: 50,913 shares

Grant/Award 1 txn

Insider Olson Tiffany

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	50,913	$3.64	$185K

Holdings After Transaction: Common Stock — 108,510 shares (Direct)

Footnotes (1)

1. F1. Represents annual restricted stock grant to non-employee directors. Grant is exempt under Rule 16b-3. The award vests upon the earlier of 12 months or the next meeting of shareholders.

Key Figures

Restricted stock grant size: 50,913 shares Grant value per share: $3.64 per share Shares owned after grant: 108,510 shares

3 metrics

Restricted stock grant size 50,913 shares Annual restricted stock grant to non-employee director Tiffany Olson

Grant value per share $3.64 per share Value used for the restricted stock award on grant date

Shares owned after grant 108,510 shares Total direct common stock holdings following the reported transaction

Key Terms

restricted stock grant, non-employee directors, Rule 16b-3, vests

4 terms

restricted stock grant financial

"Represents annual restricted stock grant to non-employee directors."

A restricted stock grant is an award of company shares given to an employee or executive that cannot be sold or transferred until certain conditions are met, such as staying with the company for a set time or hitting performance goals. For investors, it signals how the company ties pay to future performance and can affect the number of shares outstanding and management’s incentives—think of it as a wrapped gift you only keep once you meet the requirements.

non-employee directors financial

"Represents annual restricted stock grant to non-employee directors."

Non-employee directors are board members who do not work for the company as salaried employees and usually do not hold day-to-day management roles. They act like outside referees or independent coaches, providing oversight, asking tough questions, and protecting shareholders’ interests; investors care because these directors help ensure management is accountable, reduce conflicts of interest, and influence decisions that affect company strategy and long-term value.

Rule 16b-3 regulatory

"Grant is exempt under Rule 16b-3."

Rule 16b-3 is a Securities and Exchange Commission regulation that exempts certain routine, pre-approved transactions by company insiders from automatic liability for short-term trading profits. It acts like a safe harbor: if an insider follows a formal plan or the board approves specific transactions in advance, profits from buying and selling company stock within six months are not automatically reclaimed. Investors care because the rule clarifies when insider trades are permissible and reduces uncertainty about potential clawbacks.

vests financial

"The award vests upon the earlier of 12 months or the next meeting of shareholders."

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Tiffany Olson report in the latest Form 4 for MDXG?

Tiffany Olson reported receiving 50,913 shares of MiMedx common stock as a restricted stock grant. The award is part of annual compensation for non-employee directors and is not an open-market purchase or sale of shares.

At what price was Tiffany Olson’s restricted stock grant in MDXG valued?

The restricted stock grant to Tiffany Olson was valued at $3.64 per share. This value reflects the grant price used for the compensation award, rather than a price paid in an open-market transaction or sale of existing MiMedx shares.

How many MDXG shares does Tiffany Olson hold after this Form 4 transaction?

After the reported grant, Tiffany Olson directly holds 108,510 shares of MiMedx common stock. This total includes the newly granted restricted shares and reflects her direct ownership position as disclosed in the Form 4 filing.

When do Tiffany Olson’s newly granted MDXG restricted shares vest?

The restricted stock award vests upon the earlier of 12 months or the next MiMedx meeting of shareholders. Until vesting, the grant remains subject to these time-based or event-based vesting conditions set for non-employee directors.

Is Tiffany Olson’s MDXG Form 4 transaction a buy or a compensation grant?

The transaction is a compensation-related restricted stock grant, not an open-market share purchase. It is described as an annual restricted stock grant to non-employee directors and is exempt under Rule 16b-3 governing insider compensation awards.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/12/2026 - 11:27 AM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Olson Tiffany

(Last) (First) (Middle)

1775 WEST OAK COMMONS CT NE

(Street)

MARIETTA GEORGIA 30062

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
MIMEDX GROUP, INC. [ MDXG ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/10/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/10/2026		A		50,913(1)	A	$3.64	108,510	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents annual restricted stock grant to non-employee directors. Grant is exempt under Rule 16b-3. The award vests upon the earlier of 12 months or the next meeting of shareholders.

Remarks:

	/s/ William F. Hulse as attorney-in-fact Tiffany Olson	06/12/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)